Following our episodes on infectious diseases, ATMPs, and TIL therapy, the fourth episode of our podcast series Innovation & Affordability Go Hand in Hand focuses on another promising development: radiopharmaceutical therapies.

The pipeline of innovative applications in this field is impressive and promises to have a significant impact on patients in the coming years. But how do we ensure that these treatments become widely available in the Netherlands in a timely manner? And just as importantly, how do we organize this care in a sustainable and affordable way within our system?

Experts speak out
In this episode, experts from industry, clinics, and hospitals engage in conversation:

• Jan Guse, Head of Public Affairs, Novartis
• Daniela Oprea-Lager, Professor of Theranostics, Radboudumc, and Chair of the PSMA Foundation
• Jeroen Hendrikx, Hospital Pharmacist, NKI
• Marlous Kooijman, advisor at FAST

Together, they share their vision on the balance between innovation and affordability, and the concrete steps needed to give patients faster access to these groundbreaking therapies.

Listen now
In this episode (in Dutch), discover how collaboration between academia, industry, and policymakers can contribute to a future-proof healthcare system in which innovation and affordability go hand in hand. You can listen to the episode via your favorite podcast channel or directly via Springcast.